Jakarta, Aug. 23 -- Indonesia's Food and Drug Authority (BPOM) is working with Australian stakeholders to accelerate access to a new class of synthetic antibiotics aimed at combating antimicrobial resistance and supporting the country's pharmaceutical self-sufficiency.

BPOM Head Taruna Ikrar said the antibacterial drug, developed by Australia's Recce Pharmaceuticals, targets sepsis-causing pathogens and is designed to prevent antibiotic resistance.

"The product is a novel synthetic antibiotic. We welcome its development in Indonesia, especially given the growing global concern over resistance," Ikrar said in a statement on Friday.

In Australia, BPOM held talks with representatives from Investment New South Wales, Austrade, and Recce Ph...